메뉴 건너뛰기




Volumn 15, Issue 2, 2010, Pages 259-269

Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells

Author keywords

Breast cancer; Chemical biology; Chemical probe; Clioquinol; Copper dependence

Indexed keywords

8 QUINOLINOL; CLIOQUINOL; COPPER; DRUG ANALOG; PROTEASOME;

EID: 77949267166     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-009-0594-5     Document Type: Article
Times cited : (121)

References (41)
  • 1
    • 0033388950 scopus 로고    scopus 로고
    • Pipes and wiring: The regulation of copper uptake and distribution in yeast
    • DOI 10.1016/S0966-842X(99)01638-8, PII S0966842X99016388
    • S Labbe DJ Thiele 1999 Trends Microbiol 7 500 505 10.1016/S0966-842X(99) 01638-8 1:STN:280:DC%2BD3c%2Fnt12ktA%3D%3D 10603486 (Pubitemid 30017702)
    • (1999) Trends in Microbiology , vol.7 , Issue.12 , pp. 500-505
    • Labbe, S.1    Thiele, D.J.2
  • 3
    • 0037036523 scopus 로고    scopus 로고
    • Concentrations of Fe, Cu and Zn in breast tissue: A synchrotron XRF study
    • DOI 10.1088/0031-9155/47/13/310, PII S0031915502351418
    • K Geraki MJ Farquharson DA Bradley 2002 Phys Med Biol 47 2327 2339 10.1088/0031-9155/47/13/310 1:CAS:528:DC%2BD38Xmt1Ogsrs%3D 12164590 (Pubitemid 34812209)
    • (2002) Physics in Medicine and Biology , vol.47 , Issue.13 , pp. 2327-2339
    • Geraki, K.1    Farquharson, M.J.2    Bradley, D.A.3
  • 6
    • 0027448830 scopus 로고
    • Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors
    • DOI 10.1007/BF01324697
    • D Yoshida Y Ikeda S Nakazawa 1993 J Neurooncol 16 109 115 10.1007/BF01324697 1:STN:280:DyaK2c7hvVSltw%3D%3D 8289088 (Pubitemid 23304718)
    • (1993) Journal of Neuro-Oncology , vol.16 , Issue.2 , pp. 109-115
    • Yoshida, D.1    Ikeda, Y.2    Nakazawa, S.3
  • 7
    • 0343673806 scopus 로고    scopus 로고
    • Tumour vasculature as a target for anticancer therapy
    • DOI 10.1053/ctrv.1999.0158
    • MM Eatock A Schatzlein SB Kaye 2000 Cancer Treat Rev 26 191 204 10.1053/ctrv.1999.0158 1:CAS:528:DC%2BD3cXksFSqt7g%3D 10814561 (Pubitemid 30330664)
    • (2000) Cancer Treatment Reviews , vol.26 , Issue.3 , pp. 191-204
    • Eatock, M.M.1    Schatzlein, A.2    Kaye, S.B.3
  • 8
    • 0035352721 scopus 로고    scopus 로고
    • Angiogenesis: Pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs
    • DOI 10.1016/S1470-2045(00)00323-5, PII S1470204500003235
    • SB Fox G Gasparini AL Harris 2001 Lancet Oncol 2 278 289 10.1016/S1470-2045(00)00323-5 1:STN:280:DC%2BD387ntlGntw%3D%3D 11905783 (Pubitemid 33591566)
    • (2001) Lancet Oncology , vol.2 , Issue.5 , pp. 278-289
    • Fox, S.B.1    Gasparini, G.2    Harris, A.L.3
  • 9
    • 0034937998 scopus 로고    scopus 로고
    • 1:CAS:528:DC%2BD3MXkvFSrt7c%3D
    • GJ Brewer 2001 Exp Biol Med (Maywood) 226 665 673 1:CAS:528: DC%2BD3MXkvFSrt7c%3D
    • (2001) Exp Biol Med (Maywood) , vol.226 , pp. 665-673
    • Brewer, G.J.1
  • 14
    • 0038743111 scopus 로고    scopus 로고
    • The role of the ubiquitination-proteasome pathway in breast cancer. Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
    • DOI 10.1186/bcr460
    • RZ Orlowski EC Dees 2003 Breast Cancer Res 5 1 7 10.1186/bcr460 1:CAS:528:DC%2BD3sXjtlCisL0%3D 12559038 (Pubitemid 36553571)
    • (2003) Breast Cancer Research , vol.5 , Issue.1 , pp. 1-7
    • Orlowski, R.Z.1    Dees, E.C.2
  • 15
    • 0032535483 scopus 로고    scopus 로고
    • The ubiquitin-proteasome pathway: On protein death and cell life
    • DOI 10.1093/emboj/17.24.7151
    • A Ciechanover 1998 EMBO J 17 7151 7160 10.1093/emboj/17.24.7151 1:CAS:528:DyaK1MXktl2hsQ%3D%3D 9857172 (Pubitemid 29002684)
    • (1998) EMBO Journal , vol.17 , Issue.24 , pp. 7151-7160
    • Ciechanover, A.1
  • 17
    • 33646841837 scopus 로고    scopus 로고
    • Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
    • DOI 10.1074/jbc.M509043200
    • AF Kisselev A Callard AL Goldberg 2006 J Biol Chem 281 8582 8590 10.1074/jbc.M509043200 1:CAS:528:DC%2BD28XivVCgu7g%3D 16455650 (Pubitemid 43847961)
    • (2006) Journal of Biological Chemistry , vol.281 , Issue.13 , pp. 8582-8590
    • Kisselev, A.F.1    Callard, A.2    Goldberg, A.L.3
  • 18
    • 0032429122 scopus 로고    scopus 로고
    • 10.1038/sj.cdd.4400436 1:CAS:528:DyaK1MXktFKrsA%3D%3D 9894613
    • B An RH Goldfarb R Siman QP Dou 1998 Cell Death Differ 5 1062 1075 10.1038/sj.cdd.4400436 1:CAS:528:DyaK1MXktFKrsA%3D%3D 9894613
    • (1998) Cell Death Differ , vol.5 , pp. 1062-1075
    • An, B.1    Goldfarb, R.H.2    Siman, R.3    Dou, Q.P.4
  • 19
    • 0030962262 scopus 로고    scopus 로고
    • P53-dependent induction of apoptosis by proteasome inhibitors
    • DOI 10.1074/jbc.272.20.12893
    • UG Lopes P Erhardt R Yao GM Cooper 1997 J Biol Chem 272 12893 12896 10.1074/jbc.272.20.12893 1:CAS:528:DyaK2sXjtlamsrw%3D 9148891 (Pubitemid 27216701)
    • (1997) Journal of Biological Chemistry , vol.272 , Issue.20 , pp. 12893-12896
    • Lopes, U.G.1    Erhardt, P.2    Yao, R.3    Cooper, G.M.4
  • 21
    • 0033032774 scopus 로고    scopus 로고
    • Synthesis and cytotoxicity evaluation of some 8-hydroxyquinoline derivatives
    • DOI 10.1211/0022357991772826
    • AY Shen SN Wu CT Chiu 1999 J Pharm Pharmacol 51 543 548 10.1211/0022357991772826 1:CAS:528:DyaK1MXksVKhtb8%3D 10411213 (Pubitemid 29319779)
    • (1999) Journal of Pharmacy and Pharmacology , vol.51 , Issue.5 , pp. 543-548
    • Shen, A.-Y.1    Wu, S.-N.2    Chiu, C.-T.3
  • 24
    • 4644330224 scopus 로고    scopus 로고
    • Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model
    • DOI 10.1016/j.bcp.2004.05.003, PII S0006295204003065
    • AR Martirosyan R Rahim-Bata AB Freeman CD Clarke RL Howard JS Strobl 2004 Biochem Pharmacol 68 1729 1738 10.1016/j.bcp.2004.05.003 1:CAS:528: DC%2BD2cXnvV2rtbc%3D 15450938 (Pubitemid 39278495)
    • (2004) Biochemical Pharmacology , vol.68 , Issue.9 , pp. 1729-1738
    • Martirosyan, A.R.1    Rahim-Bata, R.2    Freeman, A.B.3    Clarke, C.D.4    Howard, R.L.5    Strobl, J.S.6
  • 25
    • 0033178142 scopus 로고    scopus 로고
    • Proteasome inhibitors as potential novel anticancer agents
    • DOI 10.1054/drup.1999.0095
    • QP Dou B Li 1999 Drug Resist Updates 2 215 223 10.1054/drup.1999.0095 1:CAS:528:DyaK1MXnvFCisb8%3D (Pubitemid 29526245)
    • (1999) Drug Resistance Updates , vol.2 , Issue.4 , pp. 215-223
    • Dou, Q.P.1    Li, B.2
  • 26
    • 0037376230 scopus 로고    scopus 로고
    • Potential for proteasome inhibition in the treatment of cancer
    • DOI 10.1016/S1359-6446(03)02647-3, PII S1359644603026473
    • J Adams 2003 Drug Discov Today 8 307 315 10.1016/S1359-6446(03)02647-3 1:CAS:528:DC%2BD3sXit1Kls7s%3D 12654543 (Pubitemid 36332222)
    • (2003) Drug Discovery Today , vol.8 , Issue.7 , pp. 307-315
    • Adams, J.1
  • 27
    • 23044467944 scopus 로고    scopus 로고
    • A transforming growth factor-β receptor-interacting protein frequently mutated in human ovarian cancer
    • DOI 10.1158/0008-5472.CAN-04-4385
    • WQ Ding B Liu JL Vaught H Yamauchi SE Lind 2005 Cancer Res 65 3389 3395 10.1158/0008-5472.CAN-04-4385 1:CAS:528:DC%2BD2MXjt1yrsLs%3D 15833873 (Pubitemid 41060687)
    • (2005) Cancer Research , vol.65 , Issue.15 , pp. 6526-6533
    • Ding, W.1    Tang, Q.2    Espina, V.3    Liotta, L.A.4    Mauger, D.T.5    Mulder, K.M.6
  • 30
    • 54549101998 scopus 로고    scopus 로고
    • 10.1016/j.tet.2008.09.081 1:CAS:528:DC%2BD1cXhtlWlsbnN
    • L Li B Xu 2008 Tetrahedron 64 10986 10995 10.1016/j.tet.2008.09.081 1:CAS:528:DC%2BD1cXhtlWlsbnN
    • (2008) Tetrahedron , vol.64 , pp. 10986-10995
    • Li, L.1    Xu, B.2
  • 32
    • 1542270307 scopus 로고    scopus 로고
    • Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells
    • DOI 10.1016/j.bcp.2003.10.031, PII S0006295203008876
    • KG Daniel P Gupta RH Harbach WC Guida QP Dou 2004 Biochem Pharmacol 67 1139 1151 10.1016/j.bcp.2003.10.031 1:CAS:528:DC%2BD2cXhvFSrsLw%3D 15006550 (Pubitemid 38296793)
    • (2004) Biochemical Pharmacology , vol.67 , Issue.6 , pp. 1139-1151
    • Daniel, K.G.1    Gupta, P.2    Harbach, R.H.3    Guida, W.C.4    Dou, Q.P.5
  • 33
    • 33847746963 scopus 로고    scopus 로고
    • Clioquinol, a therapeutic agent for alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts
    • DOI 10.1158/0008-5472.CAN-06-3546
    • D Chen QC Cui H Yang RA Barrea FH Sarkar S Sheng B Yan GP Reddy QP Dou 2007 Cancer Res 67 1636 1644 10.1158/0008-5472.CAN-06-3546 1:CAS:528: DC%2BD2sXhvVWqt78%3D 17308104 (Pubitemid 46383389)
    • (2007) Cancer Research , vol.67 , Issue.4 , pp. 1636-1644
    • Chen, D.1    Cui, Q.C.2    Yang, H.3    Barrea, R.A.4    Sarkar, F.H.5    Sheng, S.6    Yan, B.7    Reddy, G.P.V.8    Dou, Q.P.9
  • 38
    • 34249786569 scopus 로고    scopus 로고
    • Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy
    • DOI 10.1016/j.neuro.2007.02.004, PII S0161813X07000393
    • E Ferrada V Arancibia B Loeb E Norambuena C Olea-Azar JP Huidobro-Toro 2007 Neurotoxicology 28 445 449 10.1016/j.neuro.2007.02.004 1:CAS:528: DC%2BD2sXmtVGiurg%3D 17382398 (Pubitemid 46850765)
    • (2007) NeuroToxicology , vol.28 , Issue.3 , pp. 445-449
    • Ferrada, E.1    Arancibia, V.2    Loeb, B.3    Norambuena, E.4    Olea-Azar, C.5    Huidobro-Toro, J.P.6
  • 40
    • 54549114503 scopus 로고    scopus 로고
    • 10.1021/jm8007807 1:CAS:528:DC%2BD1cXhtFKlur%2FI 18816109
    • B Cvek V Milacic J Taraba QP Dou 2008 J Med Chem 51 6256 6258 10.1021/jm8007807 1:CAS:528:DC%2BD1cXhtFKlur%2FI 18816109
    • (2008) J Med Chem , vol.51 , pp. 6256-6258
    • Cvek, B.1    Milacic, V.2    Taraba, J.3    Dou, Q.P.4
  • 41
    • 0033826437 scopus 로고    scopus 로고
    • Cellular copper transport and metabolism
    • DOI 10.1146/annurev.nutr.20.1.291
    • ED Harris 2000 Annu Rev Nutr 20 291 310 10.1146/annurev.nutr.20.1.291 1:CAS:528:DC%2BD3cXmsVKlsr4%3D 10940336 (Pubitemid 30707983)
    • (2000) Annual Review of Nutrition , vol.20 , pp. 291-310
    • Harris, E.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.